当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:161.84亿  总市值:162.73亿
流通股本:4.16亿   总股本:4.18亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金726,174,326.793,608,810,283.532,221,551,326.831,381,650,198.94
  收到的税费返还-428,944.25428,944.25423,280.12
  收到其他与经营活动有关的现金54,979,606.38303,035,186.4216,310,532.78106,792,822.46
  经营活动现金流入小计781,153,933.173,912,274,414.182,438,290,803.861,488,866,301.52
  购买商品、接受劳务支付的现金468,260,065.571,946,531,447.591,322,372,298.42856,595,638.9
  支付给职工以及为职工支付的现金288,309,965.331,056,596,892.61865,417,929.27568,693,422.12
  支付的各项税费42,735,734.05135,022,456.7794,872,008.871,442,003.23
  支付其他与经营活动有关的现金163,201,724.33837,338,459.73592,301,658.12405,972,953.4
  经营活动现金流出小计962,507,489.283,975,489,256.72,874,963,894.611,902,704,017.65
  经营活动产生的现金流量净额-181,353,556.11-63,214,842.52-436,673,090.75-413,837,716.13
二、投资活动产生的现金流量:
  收回投资收到的现金1,715,836,006.296,011,331,867.584,693,110,320.323,127,398,450.95
  取得投资收益收到的现金16,513,434.4273,316,859.5457,450,047.0137,699,529.61
  处置固定资产、无形资产和其他长期资产收回的现金净额365,380.476,054,606.513,529,744.893,304,010.28
  处置子公司及其他营业单位收到的现金净额6.92---
  投资活动现金流入小计1,732,714,828.16,090,703,333.634,754,090,112.223,168,401,990.84
  购建固定资产、无形资产和其他长期资产支付的现金173,315,399.68505,923,268.2275,362,984.95251,850,582.61
  投资支付的现金1,473,589,292.966,597,967,366.825,237,461,623.83,437,191,534.05
  支付其他与投资活动有关的现金-12,001,775.7312,001,775.7312,001,775.73
  投资活动现金流出小计1,646,904,692.647,115,892,410.755,524,826,384.483,701,043,892.39
  投资活动产生的现金流量净额85,810,135.46-1,025,189,077.12-770,736,272.26-532,641,901.55
三、筹资活动产生的现金流量:
  取得借款收到的现金-570,960,000570,960,000570,960,000
  收到其他与筹资活动有关的现金-69,200,21569,200,21569,200,215
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-640,160,215640,160,215640,160,215
  偿还债务支付的现金28,898,000434,441,873.18418,441,873.18224,963,873.18
  分配股利、利润或偿付利息支付的现金3,708,331.3517,284,157.5513,440,306.288,573,749.14
  支付其他与筹资活动有关的现金8,167,141.9338,575,658.0428,233,401.7819,449,739.59
  筹资活动现金流出小计40,773,473.28490,301,688.77460,115,581.24252,987,361.91
  筹资活动产生的现金流量净额-40,773,473.28149,858,526.23180,044,633.76387,172,853.09
四、汇率变动对现金及现金等价物的影响-17,034,709.79-1,550,675.117,022,116.6111,951,421.83
五、现金及现金等价物净增加额-153,351,603.72-940,096,068.52-1,020,342,612.64-547,355,342.76
  加:期初现金及现金等价物余额1,758,321,155.882,698,417,224.42,698,417,224.42,698,417,224.4
  期末现金及现金等价物余额1,604,969,552.161,758,321,155.881,678,074,611.762,151,061,881.64
补充资料:
  净利润--637,805,702.62-4,144,746.19
  资产减值准备-485,627,267.37-123,902,940.59
  固定资产和投资性房地产折旧-408,396,255.92-185,266,494.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-408,396,255.92-185,266,494.73
  无形资产摊销-76,038,256.62-34,315,001.67
  长期待摊费用摊销-49,510,967.53-21,560,556.68
  处置固定资产、无形资产和其他长期资产的损失-336,061.07-1,785,189.01
  固定资产报废损失-4,356,878.64-2,645,775.93
  公允价值变动损失-11,291,407.29--9,210,174.71
  财务费用--16,866,315.43-9,285,559.84
  投资损失--12,957,568.69--18,665,756.39
  递延所得税--14,018,941.29--50,545,313.11
  其中:递延所得税资产减少--5,550,624.09--38,588,539.49
    递延所得税负债增加--8,468,317.2--11,956,773.62
  存货的减少-86,419,672.02-50,000,311.05
  经营性应收项目的减少--244,438,338.19--336,509,883.07
  经营性应付项目的增加--234,769,844.39--450,216,467.1
  其他--57,852,628.01--
  不涉及现金收支的投资和筹资活动金额其他项目-65,287,712.95-52,537,066.4
  现金的期末余额-1,758,321,155.88-2,151,061,881.64
  减:现金的期初余额-2,698,417,224.4-2,698,417,224.4
  现金及现金等价物的净增加额--940,096,068.52--547,355,342.76
公告日期2026-04-252026-04-252025-10-242025-08-23
审计意见(境内)标准无保留意见
TOP↑